Projects per year
Personal profile
Research Strategic Pillar
Dr. Randall Urban, VP and Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the next badge(s):
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research Strategic Pillar Keywords
- Brain Health
- Specialized Health
- Metabolic Health
- Life Span Health
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Jessica E Justman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 54 Finished
-
ICAP Clinical Trials Unit
El-Sadr, W. M. (PI) & Justman, J. E. (CoPI)
National Institute of Allergy and Infectious Diseases
12/1/20 → 11/30/21
Project: Research project
-
POPULAR-BASED HIV IMPACT ASSESSMENTS IN RESOURCE-CONSTRAINED STEEINGS UNDER PEPFAR
Justman, J. E. (PI)
Centers for Disease Control and Prevention, Center for Global Health
9/30/14 → 9/29/19
Project: Research project
-
POPULAR-BASED HIV IMPACT ASSESSMENTS IN RESOURCE-CONSTRAINED STEEINGS UNDER PEPFAR
Justman, J. E. (PI)
Centers for Disease Control and Prevention, Center for Global Health
9/30/14 → 9/29/19
Project: Research project
-
GH13-1368 GLOBAL TECHNICAL ASSISTANCE
Justman, J. E. (PI)
Centers for Disease Control and Prevention, Center for Global Health
9/30/13 → 3/31/19
Project: Research project
-
GH13-1368 GLOBAL TECHNICAL ASSISTANCE
Justman, J. E. (PI)
Centers for Disease Control and Prevention, Center for Global Health
9/30/13 → 3/31/19
Project: Research project
-
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial
HPTN 083 study group, Nov 2023, In: The Lancet HIV. 10, 11, p. e703-e712Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus) -
Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design Project
for the Forum for Collaborative Research Recency Assay Working Group, Jul 2023, In: Clinical Pharmacology and Therapeutics. 114, 1, p. 29-40 12 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Citations (Scopus) -
Risk of COVID-19 after natural infection or vaccination
the NIAID-funded COVID-19 Prevention Network (CoVPN), Oct 2023, In: eBioMedicine. 96, 104799.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study
ECHO Trial Consortium, Aug 2021, In: The Lancet HIV. 8, 8, p. e495-e501Research output: Contribution to journal › Article › peer-review
Open Access17 Citations (Scopus) -
Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial
the ECHO Trial Consortium, May 1 2020, In: Journal of the International AIDS Society. 23, 5, e25491.Research output: Contribution to journal › Article › peer-review
Open Access16 Citations (Scopus)